SECO, a leading company in the hi-tech sector, specialized in computer miniaturization, backed by FITEC, a fund managed by Fondo Italiano d’Investimento SGR, partnerring with IBD, an innovative Italian company operating in the biomedical market, for the development of Biorespira, a new non-invasive pulmonary ventilator created in response to the current health emergency of the COVID‑19 pandemic.
SECO is an Italian group with a leading global position in the sector of embedded technology and Internet of Things (IoT). Since 1979, it has been designing and producing embedded systems – industrial computers that are integrated into a client’s machine or tool, activating its functions and permitting interaction through touch/video interfaces. SECO collaborates with a broad network of strategic suppliers in the international high-tech panorama (including Intel®, AMD, NXP, NVIDIA®, Wind, and Telenor), as well as with universities, research centers and innovative start-ups, and operates on a global scale with offices in Italy, Germany, the U.S., India and Taiwan, employing more than 380 people. The industrial sectors in which SECO products are utilized range from biomedicine to wellness, industrial automation to transportation, and it has clients that are market leaders, such as Cimbali, Esaote, Evoca, and Technogym.
Research and development of Medical Devices
Conceived in London & founded in Italy in 2014
en iso 13485 and
en iso 9001
Over 1 million € from investors & announcements
Developed and certified an innovative device for hemodialysis
IBD is a biomedical devices manufacturer company conceived in London and founded in Italy in 2014. Guided by a team with +10 years of experience in dialysis and medical device design, IBD has raised so far over € 1 million in funding by angel investors and grants. It is now facing a new round of funding.
Contact us to learn more about Biorespira
Please provide the following information and we will get back to you quickly with more information on your request.